May 25, 2022CorporateTerumo Blood and Cell Technologies Inaugurates Second Manufacturing Facility in Colorado
May 17, 2022CorporateTerumo Pharmaceutical Solutions Offers Pre-Fillable Syringe Solutions for Demanding Low Dose Applications Such as Ophthalmic
May 16, 2022CorporateTerumo Announces Change in Indication for Dexcom G6 CGM System in Japan Adjunctive use of Blood Glucose Meter Principally Not Required
Site Map Show — Site Map Hide — Site Map What’s new News Press Inquiries About Terumo Dear Stakeholders Terumo Group Identity Terumo Group Code of Conduct Corporate Profile Corporate Governance Compliance Procurement Activity Regulations and Standards Directors and Executive Officers History Our Stories Terumo's Response to COVID-19 Business Overview TIS Division (Terumo Interventional Systems) Neurovascular Division (MicroVention) Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division Vascular Graft Division (Terumo Aortic) Hospital Care Solutions Division / Life Care Solutions Division Pharmaceutical Solutions Division Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies) Sustainability Sustainability News Message from Top Management Sustainability at the Terumo Group Creating a Diverse and Inclusive Workplace Reducing Environmental Footprint Serving Our Communities Report Library GRI Standards Index Technology Basic Information Research and Development Production and Supply Intellectual Property Investors Management Policy Management Policy Top Management Message Business Risks Disclaimer IR Policy IR Library Financial Statements Presentations Terumo Reports IR Events IR Inquiries Financial Highlights Shareholders & Stock Shareholders Meeting Stock Information Shareholder Return Credit Ratings and Corporate Bond Analyst Coverage Articles of Incorporation Site Quote Terms and Conditions of Use Privacy Policy Social Media Policy
Top
Top